You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.

DUBLIN--(BUSINESS WIRE)--The "Global DNA Damage Response Drugs Market: Focus on Commercialized Drugs, Potential Pipeline Drugs, Application, Country Data (13 Countries), and Competitive Landscape - Analysis and Forecast, 2020-2030" report has been added to ResearchAndMarkets.com's offering. The DNA damage response drugs industry is one of the most rapidly evolving markets. The global market for DNA damage response drugs is predicted to grow at a CAGR of 21.33% over the forecast period of 2020-2030. The market is driven by certain factors, which include the rising global prevalence of cancer, favorable reimbursement scenario, increasing oncology R&D expenditure, and an increase in the adoption of precision medicine in cancer treatment. The market is favored by the developments in the field of oncology research for discovering underlying molecular mechanisms of cancerous cells for the development of novel therapeutics. Moreover, the growing cases of advanced cancer worldwide has significantly escalated the need for developing DNA damage response drugs for solving cancer unmet needs. These drugs have unprecedented potential in terms of offering a selective and efficient tolerated treatment approach for improving cancer survival rates. Within the research report, the market is segmented on the basis of commercialized drugs, pipeline analysis (by mechanism of action), application, and region. The commercialized drugs segment contains the revenue which is expected to be generated by the successful launch of commercialized drugs that are in Phase III clinical trials and are being evaluated for other cancer indications based on different biomarkers. The pipeline analysis (by mechanism of action) segment covers non-commercialized DNA damage response drugs that are currently in Phase III clinical trials and are being developed as a monotherapy treatment for various cancer indications. Each of these segments covers the snapshot of the market over the projected years, the inclination of the market revenue, underlying patterns, and trends by using analytics on the primary and secondary data obtained. Key Questions Answered in this Report: Key Topics Covered: 1 Product Definition 2 Research Scope 3 Research Methodology 4 Market Overview 5 Industry Insights 6 Market Dynamics 7 Competitive Landscape 8 Epidemiology Analysis for DNA Damage Response Drugs 9 Clinical Landscape 10 Global DNA Damage Response Drugs Market, by Commercialized Drugs ($Million), 2019-2030 11 DNA Damage Response Drugs, by Potential Pipeline Drugs 12 Global DNA Damage Response Drugs Market, by Application, ($Million), 2019-2030 13 Global DNA Damage Response Drugs Market, by Region ($Million), 2019-2030 14 Company Profiles For more information about this report visit https://www.researchandmarkets.com/r/z9g7w4 About ResearchAndMarkets.com ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Answer: Global DNA Damage Response Drugs Market to Reach $24,848.8 Million by 2030 - ResearchAndMarkets.com